ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,043
0,00%
Bitcoin
96.649,60
-0,57%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Cyclerion Therapeutics Inc (CYCN) Börsenkurse

Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc (CYCN)

NASDAQ
3,19
0,24
(8,14%)
Geschlossen 22 Dezember 10:00PM
Verzögert um 15 Minuten
3,3998
0,2098
(6,58%)
Nach Börsenschluss: 1:57AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
3,3998
Gebot
1,65
Fragen
4,78
Volumen
269.561
2,8345 Tagesbereich 3,43
1,27 52-Wochen-Bereich 9,4699
Marktkapitalisierung
9,214M
Handelsende
2,95
Handelsbeginn
3,03
Letzte Trade
10
@
3.35
Letzter Handelszeitpunkt
Finanzvolumen
US$ 843.767
VWAP
3,1302
Durchschnittliches Volumen (3 Mio.)
3.262.228
Ausgegebene Aktien
2.710.096
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,64
Gewinn pro Aktie (EPS)
-1,94
Erlöse
-
Nettogewinn
-5,26M

Über Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of nex... Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.cyclerion.com
Hauptsitz
Boston, Massachusetts, USA
Gegründet
-
Cyclerion Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CYCN. The last closing price for Cyclerion Therapeutics was US$2,95. Over the last year, Cyclerion Therapeutics shares have traded in a share price range of US$ 1,27 to US$ 9,4699.

Cyclerion Therapeutics currently has 2.710.096 shares in issue. The market capitalisation of Cyclerion Therapeutics is US$7,99 million. Cyclerion Therapeutics has a price to earnings ratio (PE ratio) of -1.64.

CYCN Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

17 Dezember 2024
Edgar (US Regulatory)

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Company’s next stage of growth. The...

17 Dezember 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 August 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 August 2024
Edgar (US Regulatory)

Regina Graul, Ph.D., Promoted to Chief Executive Officer

CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul, Ph.D., has been promoted to Chief Executive Officer...

07 August 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 August 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 Juni 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 Mai 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

26 Januar 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.1535-4.31992795433.55333.792.82375483.07223349CS
42.0698155.624060151.339.46991.2793811205.52767997CS
120.709826.38661710042.699.46991.2732622285.30400294CS
261.209855.24200913242.199.46991.2715070075.29876907CS
52-1.4802-30.33196721314.889.46991.277669135.29495151CS
156-32.4002-90.503351955335.837.81.273600427.94263528CS
260-40.6002-92.273181818244179.21.2745124342.55667051CS

CYCN - Frequently Asked Questions (FAQ)

What is the current Cyclerion Therapeutics share price?
The current share price of Cyclerion Therapeutics is US$ 3,3998
How many Cyclerion Therapeutics shares are in issue?
Cyclerion Therapeutics has 2.710.096 shares in issue
What is the market cap of Cyclerion Therapeutics?
The market capitalisation of Cyclerion Therapeutics is USD 7,99M
What is the 1 year trading range for Cyclerion Therapeutics share price?
Cyclerion Therapeutics has traded in the range of US$ 1,27 to US$ 9,4699 during the past year
What is the PE ratio of Cyclerion Therapeutics?
The price to earnings ratio of Cyclerion Therapeutics is -1,64
What is the reporting currency for Cyclerion Therapeutics?
Cyclerion Therapeutics reports financial results in USD
What is the latest annual profit for Cyclerion Therapeutics?
The latest annual profit of Cyclerion Therapeutics is USD -5,26M
What is the registered address of Cyclerion Therapeutics?
The registered address for Cyclerion Therapeutics is 155 FEDERAL STREET, SUITE 700, BOSTON, MASSACHUSETTS, 02110
What is the Cyclerion Therapeutics website address?
The website address for Cyclerion Therapeutics is www.cyclerion.com
Which industry sector does Cyclerion Therapeutics operate in?
Cyclerion Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
CYCN
Cyclerion Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten